ClinicalTrials.govpublic full text
Regorafenib Plus PD-1 Inhibitor in Patients With Colorectal Cancer
colorectal cancer, immunotherapy, regorafenib, nivoluamb, microsatellite stable, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 914800
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.